Therapeutic Outcomes of Methimazole in Hyperthyroidism Patients
Journal of Endocrinology and Metabolism · 2026-06 · 16 (3) · 148-156
DOI: 10.14740/jem1602 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Endocrinology and Metabolism, 2026-06. Verfasst von Raed Al-Dahash und 10 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Al-Dahash, R., Almarzoqi, M., Alenazi, F., Alibrahim, A., Alrabah, S., Aljohani, A., Alsadhan, S., Alguraibi, A., Almutairi, M., Athuwaybi, S., & Alsaber, A. (2026). Therapeutic Outcomes of Methimazole in Hyperthyroidism Patients. Journal of Endocrinology and Metabolism, 16(3), 148-156. https://doi.org/10.14740/jem1602
Vancouver
Al-Dahash R, Almarzoqi M, Alenazi F, Alibrahim A, Alrabah S, Aljohani A, et al. Therapeutic Outcomes of Methimazole in Hyperthyroidism Patients. Journal of Endocrinology and Metabolism. 2026;16(3):148-156. doi:10.14740/jem1602
BibTeX
@article{AlDahash2026,
author = {Al-Dahash, Raed and Almarzoqi, Mohammad and Alenazi, Fahad and Alibrahim, Ahmed and Alrabah, Saud and Aljohani, Abdulrahman and Alsadhan, Saud and Alguraibi, Abdullah and Almutairi, Majed and Athuwaybi, Sultan and Alsaber, Abdularahman},
title = {Therapeutic Outcomes of Methimazole in Hyperthyroidism Patients},
journal = {Journal of Endocrinology and Metabolism},
year = {2026},
volume = {16},
number = {3},
pages = {148--156},
doi = {10.14740/jem1602}
}
EUVIMED